Targeting Ras in myeloid leukemias.

Abstract excerpt

Ras proteins normally relay growth-promoting signals from many activated cell surface receptors, and they are altered by oncogenic point mutations in approximately 30% of human cancers. Activating KRAS and NRAS mutations are especially common in malignancies of the pancreas, lung, and colon, and in myeloid leukemia. Here, we discuss general strategies for targeting hyperactive Ras signaling in cancer cells with...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to KRAS gene
• Share to NRAS gene
• Share to Genes, ras